RISE Life Science Corp. (CNSX:RLSC) announced a brokered private placement of up to 200,000,000 units at a price of CAD 0.05 per unit for gross proceeds of CAD 10,000,000 on April 13, 2020. Each unit will be comprised of one common share and one common share purchase warrant. Each warrant will entitle the holder to purchase one common share at a price of CAD 0.07 per common share for a period of 24 months from the date of closing. The company will pay a commission and broker warrants in the transaction. On April 21, 2020, the company announced that it intends to complete the transaction, led by Canaccord Genuity Corp. for a fee of 8% of the gross proceeds received and 8% of such number of warrants expiring three years following the closing of the closing.